The average one-year price target for Ginkgo Bioworks Holdings (NYSE:DNA) has been revised to $10.88 / share. This is a decrease of 11.11% from the prior estimate of $12.24 dated November 7, 2025. The ...
Ginkgo Bioworks Holdings, Inc. (DNA) shares rallied 18.9% in the last trading session to close at $11.25. This move can be attributable to notable volume with a higher number of shares being traded ...
Hosted on MSN
Ginkgo Bioworks Holdings, Inc. (DNA) stock drops despite market gains: Important facts to note
Ginkgo Bioworks Holdings, Inc. (DNA) closed at $10.02 in the latest trading session, marking a -6.36% move from the prior day. This change lagged the S&P 500's 0.03% gain on the day. Elsewhere, the ...
The chart has 2 X axes displaying Time, and Time. The chart has 2 Y axes displaying symbol price, and symbol volume. Created with Highcharts 12.5.0 ...
Ginkgo Bioworks is undergoing a foundational strategic shift, moving decisively toward a fully automated laboratory infrastructure. This transformation, which follows the divestiture of its ...
Analysts have been trimming their price targets on Ginkgo Bioworks Holdings, with bullish views moving to about US$12 from ...
Ginkgo Bioworks reported Q4 revenues of $33 million, down 24% year-over-year, and missing estimates by over $4 million. Cell Engineering, expected to drive growth, delivered just $125 million in 2025 ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results